Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

The risk for recurrent cardiovascular events is high among patients with r-axSpA and a history of these events, though TNF inhibitor therapy may offer protective benefits.

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

A study identified use of certain medications (eg, NSAIDs), comorbid conditions, and symptoms as risk factors for ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...

Efficacy and Safety of Paracetamol, Phenylephrine and Chlorpheniramine maleate FDC in Common Cold - ...

[21] However, the ranking of NSAIDs as inhibitors of COX and interpretation of rank orders to inform evidence of clinical toxicity has continued unabated. As would be anticipated with the ...

"Very lame and imperfect theories are sufficient to suggest useful experiments which serve to correct those theories and give birth to others more perfect. These, then occasion farther experiments ...

Both Ozempic and Mounjaro are GLP-1 inhibitors meant to help people with diabetes, but they are often used for weight loss. He said the GLP-1 “seems to have fewer side effects and be more ...

Simultaneously, Epirium announced today the transition of Russell Cox, President and Chief Executive Officer (CEO), to the role of Executive Chairman and the appointment of Alex Casdin ...

dipeptidyl peptidase 4 inhibitors, according to data ... In a per-protocol analysis, Cox regression showed that GLP-1 receptor agonist users had lower risks for major adverse cardiac events ...